中国血栓性疾病防治指南

2018-10-15 《中国血栓性疾病防治指南》专家委员会 中华医学杂志.2018, 98(36):2861-2888.

本指南的制订遵循世界卫生组织及中华医学会关于制订临床诊疗指南的方法及程序 。指南专家委员会由临床专家、信息学专家、决策科学家和系统综述与指南方法学专家共同组成,也包含了无相关研究背景的临床医师,使指南推荐意见具有更强的实用性。指南制订的过程充分反映了目前的循证医学观念 ,临床专家和循证医学专家互相讨论,共同检索、评价和分级相关研究证据,以确保证据纳入和评价既全面、客观,又紧密结合临床。应该指出的是

中文标题:

中国血栓性疾病防治指南

发布日期:

2018-10-15

简要介绍:

本指南的制订遵循世界卫生组织及中华医学会关于制订临床诊疗指南的方法及程序 。指南专家委员会由临床专家、信息学专家、决策科学家和系统综述与指南方法学专家共同组成,也包含了无相关研究背景的临床医师,使指南推荐意见具有更强的实用性。指南制订的过程充分反映了目前的循证医学观念 ,临床专家和循证医学专家互相讨论,共同检索、评价和分级相关研究证据,以确保证据纳入和评价既全面、客观,又紧密结合临床。应该指出的是,本指南不具有法律效力。本指南尚不能涵盖所有复杂的临床情况,指南发布时可能存在某些最新研究结论由于滞后发表未被收入指南的情况;指南的证据也可能受到原始研究质量及方法学的影响;受我国当前该领域的实际研究水平所限,指南中基于国内研究的证据有限。 

拓展指南:血栓相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国血栓性疾病防治指南)] GetToolGuiderByIdResponse(projectId=1, id=9c6711c0016ea294, title=中国血栓性疾病防治指南, enTitle=, guiderFrom=中华医学杂志.2018, 98(36):2861-2888., authorId=null, author=, summary=本指南的制订遵循世界卫生组织及中华医学会关于制订临床诊疗指南的方法及程序 。指南专家委员会由临床专家、信息学专家、决策科学家和系统综述与指南方法学专家共同组成,也包含了无相关研究背景的临床医师,使指南推荐意见具有更强的实用性。指南制订的过程充分反映了目前的循证医学观念 ,临床专家和循证医学专家互相讨论,共同检索、评价和分级相关研究证据,以确保证据纳入和评价既全面、客观,又紧密结合临床。应该指出的是, cover=, journalId=null, articlesId=null, associationId=1737, associationName=《中国血栓性疾病防治指南》专家委员会, associationIntro=, copyright=0, guiderPublishedTime=Mon Oct 15 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>本指南的制订遵循世界卫生组织及中华医学会关于制订临床诊疗指南的方法及程序 。指南专家委员会由临床专家、信息学专家、决策科学家和系统综述与指南方法学专家共同组成,也包含了无相关研究背景的临床医师,使指南推荐意见具有更强的实用性。指南制订的过程充分反映了目前的循证医学观念 ,临床专家和循证医学专家互相讨论,共同检索、评价和分级相关研究证据,以确保证据纳入和评价既全面、客观,又紧密结合临床。应该指出的是,本指南不具有法律效力。本指南尚不能涵盖所有复杂的临床情况,指南发布时可能存在某些最新研究结论由于滞后发表未被收入指南的情况;指南的证据也可能受到原始研究质量及方法学的影响;受我国当前该领域的实际研究水平所限,指南中基于国内研究的证据有限。 </div> <div><br> </div>拓展指南:<strong>与<font color="red">血栓</font>相关指南:</strong><br><ul><li><a title="2018 ASH静脉血栓栓塞管理指南:儿童静脉血栓栓塞症的治疗" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=36f821c0016e2935">2018 ASH静脉血栓栓塞管理指南:儿童静脉血栓栓塞症的治疗</a></li> <li><a title="2018 ASH静脉血栓栓塞管理指南:肝素诱导的血小板减少症" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=4f88f1c0016e277b">2018 ASH静脉血栓栓塞管理指南:肝素诱导的血小板减少症</a></li> <li><a title="2018 ASH静脉血栓栓塞管理指南:妊娠期间静脉血栓栓塞" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=28b201c0016e252e">2018 ASH静脉血栓栓塞管理指南:妊娠期间静脉血栓栓塞</a></li> <li><a title="2018 ASH静脉血栓栓塞管理指南:住院与非住院患者静脉血栓栓塞的预防" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=1aa711c0016e22f9">2018 ASH静脉血栓栓塞管理指南:住院与非住院患者静脉血栓栓塞的预防</a></li> <li><a title="2018 ASH静脉血栓栓塞管理指南:优化抗凝治疗管理" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=5bb711c0016e175b">2018 ASH静脉血栓栓塞管理指南:优化抗凝治疗管理</a></li> 更多信息请点击:<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E6%A0%93">有关血栓更多指南</a></ul>, tagList=[TagDto(tagId=84146, tagName=血栓性疾病)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=15445, appHits=1067, showAppHits=18, pcHits=7203, showPcHits=9220, likes=132, shares=76, comments=17, approvalStatus=1, publishedTime=Mon Dec 10 22:45:21 CST 2018, publishedTimeString=2018-10-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Dec 10 22:45:21 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:26:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国血栓性疾病防治指南)])
中国血栓性疾病防治指南
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2111877, encodeId=151c21118e718, content=下载中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:33:46 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2111875, encodeId=5cce21118e52a, content=提纲挈领, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:24:31 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=978526, encodeId=ca9b9e852683, content=希望不需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f2633840, createdName=2451920356, createdTime=Thu Jul 01 09:58:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976760, encodeId=8ed59e6760a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Fri Jun 25 11:08:17 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963652, encodeId=5321963652c8, content=求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5705495242, createdName=caga, createdTime=Sat May 08 10:29:36 CST 2021, time=2021-05-08, status=1, ipAttribution=)]
    2023-01-28 1463eea1m97暂无昵称 来自陕西省

    下载中

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2111877, encodeId=151c21118e718, content=下载中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:33:46 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2111875, encodeId=5cce21118e52a, content=提纲挈领, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:24:31 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=978526, encodeId=ca9b9e852683, content=希望不需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f2633840, createdName=2451920356, createdTime=Thu Jul 01 09:58:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976760, encodeId=8ed59e6760a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Fri Jun 25 11:08:17 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963652, encodeId=5321963652c8, content=求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5705495242, createdName=caga, createdTime=Sat May 08 10:29:36 CST 2021, time=2021-05-08, status=1, ipAttribution=)]
    2023-01-28 1463eea1m97暂无昵称 来自陕西省

    提纲挈领

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2111877, encodeId=151c21118e718, content=下载中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:33:46 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2111875, encodeId=5cce21118e52a, content=提纲挈领, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:24:31 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=978526, encodeId=ca9b9e852683, content=希望不需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f2633840, createdName=2451920356, createdTime=Thu Jul 01 09:58:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976760, encodeId=8ed59e6760a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Fri Jun 25 11:08:17 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963652, encodeId=5321963652c8, content=求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5705495242, createdName=caga, createdTime=Sat May 08 10:29:36 CST 2021, time=2021-05-08, status=1, ipAttribution=)]
    2021-07-01 2451920356

    希望不需要积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2111877, encodeId=151c21118e718, content=下载中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:33:46 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2111875, encodeId=5cce21118e52a, content=提纲挈领, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:24:31 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=978526, encodeId=ca9b9e852683, content=希望不需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f2633840, createdName=2451920356, createdTime=Thu Jul 01 09:58:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976760, encodeId=8ed59e6760a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Fri Jun 25 11:08:17 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963652, encodeId=5321963652c8, content=求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5705495242, createdName=caga, createdTime=Sat May 08 10:29:36 CST 2021, time=2021-05-08, status=1, ipAttribution=)]
    2021-06-25 xzmynya

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2111877, encodeId=151c21118e718, content=下载中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:33:46 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2111875, encodeId=5cce21118e52a, content=提纲挈领, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230128/5bbe75c57c6a4ba9894a2a0a98ca9582/c7761866d29a41f6af7ccc35e124717f.jpg, createdBy=be255123633, createdName=1463eea1m97暂无昵称, createdTime=Sat Jan 28 17:24:31 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=978526, encodeId=ca9b9e852683, content=希望不需要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c78f2633840, createdName=2451920356, createdTime=Thu Jul 01 09:58:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976760, encodeId=8ed59e6760a6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160531/IMG574DA473DF46C6923.jpg, createdBy=e39768313, createdName=xzmynya, createdTime=Fri Jun 25 11:08:17 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963652, encodeId=5321963652c8, content=求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5705495242, createdName=caga, createdTime=Sat May 08 10:29:36 CST 2021, time=2021-05-08, status=1, ipAttribution=)]
    2021-05-08 caga

    求积分

    0